Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine

Background Reconstructed embryos from terminally differentiated somatic cells have revealed high levels of genomic methylation which results in inappropriate expression patterns of imprinted and non-imprinted genes. These aberrant expressions are probably responsible for different abnormalities duri...

Full description

Bibliographic Details
Main Authors: Farnoosh Jafarpour, Sayed Morteza Hosseini, Mahdi Hajian, Mohsen Forouzanfar, Parvaneh Abedi, Laleh Hosseini, Somaye Ostadhosseini, Soghra Gholami, Mohammad Hossein Nasr Esfahani
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2011-01-01
Series:International Journal of Fertility and Sterility
Subjects:
Online Access:http://www.ijfs.ir/article_45069_0fbede76ae076f8b851bc96d3cbede2b.pdf
_version_ 1831716146261262336
author Farnoosh Jafarpour
Sayed Morteza Hosseini
Mahdi Hajian
Mohsen Forouzanfar
Parvaneh Abedi
Laleh Hosseini
Somaye Ostadhosseini
Soghra Gholami
Mohammad Hossein Nasr Esfahani
author_facet Farnoosh Jafarpour
Sayed Morteza Hosseini
Mahdi Hajian
Mohsen Forouzanfar
Parvaneh Abedi
Laleh Hosseini
Somaye Ostadhosseini
Soghra Gholami
Mohammad Hossein Nasr Esfahani
author_sort Farnoosh Jafarpour
collection DOAJ
description Background Reconstructed embryos from terminally differentiated somatic cells have revealed high levels of genomic methylation which results in inappropriate expression patterns of imprinted and non-imprinted genes. These aberrant expressions are probably responsible for different abnormalities during the development of clones. Improvement in cloning competency may be achieved through modification of epigenetic markers in donor cells. Materials and Methods Our objective was to determine if treatment of donor cells for 72 hours with 5-aza-2'-deoxycytidine (5-aza-dc; 0-0.3 μM), a DNA methyl transferase inhibitor, improved development and expression of Oct-4. Results In comparison with untreated cells, 0.01 and 0.08 μM 5-aza-dc treated cells insignificantly decreased the blastocyst rate (32.1% vs. 28.6% and 27.2%, respectively) while it was significant for 0.3 μM treated cells (6.5%). Embryo quality as measured by the total cell number (TCN) decreased in a dose-related fashion, which was significant at 0.08 and 0.3 μM 5-aza-dc treated cells when compared with 0 and 0.01 μM 5-aza-dc treated cells. Although reconstructed embryos from 0.08 and 0.3 μM 5-aza-dc treated cells showed lower levels of DNA methylation and histone H3 acetylation, development to blastocyst stage was decreased. The epigenetic markers of embryos cloned from 0.01 μM 5-aza-dc remained unchanged. Conclusion These results show that 5-aza-dc is not a suitable choice for modifying nuclear reprogramming. Finally, it was concluded that the wide genomic hypomethylation induced by 5-aza-dc deleteriously impacts the developmental competency of cloned embryos.
first_indexed 2024-12-21T00:33:16Z
format Article
id doaj.art-233355ba492746a291ac768a389aec8e
institution Directory Open Access Journal
issn 2008-076X
2008-0778
language English
last_indexed 2024-12-21T00:33:16Z
publishDate 2011-01-01
publisher Royan Institute (ACECR), Tehran
record_format Article
series International Journal of Fertility and Sterility
spelling doaj.art-233355ba492746a291ac768a389aec8e2022-12-21T19:21:50ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782011-01-014414815545069Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidineFarnoosh Jafarpour0Sayed Morteza Hosseini1Mahdi Hajian2Mohsen Forouzanfar3Parvaneh Abedi4Laleh Hosseini5Somaye Ostadhosseini6Soghra Gholami7Mohammad Hossein Nasr Esfahani8Department of Anatomy and Embryology, School of Veterinary Medicine, Shiraz University, Shiraz, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranSchool of Sciences, Islamic Azad University, Marvdasht Branch, Marvdasht, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranDepartment of Anatomy and Embryology, School of Veterinary Medicine, Shiraz University, Shiraz, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranBackground Reconstructed embryos from terminally differentiated somatic cells have revealed high levels of genomic methylation which results in inappropriate expression patterns of imprinted and non-imprinted genes. These aberrant expressions are probably responsible for different abnormalities during the development of clones. Improvement in cloning competency may be achieved through modification of epigenetic markers in donor cells. Materials and Methods Our objective was to determine if treatment of donor cells for 72 hours with 5-aza-2'-deoxycytidine (5-aza-dc; 0-0.3 μM), a DNA methyl transferase inhibitor, improved development and expression of Oct-4. Results In comparison with untreated cells, 0.01 and 0.08 μM 5-aza-dc treated cells insignificantly decreased the blastocyst rate (32.1% vs. 28.6% and 27.2%, respectively) while it was significant for 0.3 μM treated cells (6.5%). Embryo quality as measured by the total cell number (TCN) decreased in a dose-related fashion, which was significant at 0.08 and 0.3 μM 5-aza-dc treated cells when compared with 0 and 0.01 μM 5-aza-dc treated cells. Although reconstructed embryos from 0.08 and 0.3 μM 5-aza-dc treated cells showed lower levels of DNA methylation and histone H3 acetylation, development to blastocyst stage was decreased. The epigenetic markers of embryos cloned from 0.01 μM 5-aza-dc remained unchanged. Conclusion These results show that 5-aza-dc is not a suitable choice for modifying nuclear reprogramming. Finally, it was concluded that the wide genomic hypomethylation induced by 5-aza-dc deleteriously impacts the developmental competency of cloned embryos.http://www.ijfs.ir/article_45069_0fbede76ae076f8b851bc96d3cbede2b.pdfepigenesisnuclear reprogrammingnuclear transfer
spellingShingle Farnoosh Jafarpour
Sayed Morteza Hosseini
Mahdi Hajian
Mohsen Forouzanfar
Parvaneh Abedi
Laleh Hosseini
Somaye Ostadhosseini
Soghra Gholami
Mohammad Hossein Nasr Esfahani
Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
International Journal of Fertility and Sterility
epigenesis
nuclear reprogramming
nuclear transfer
title Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
title_full Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
title_fullStr Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
title_full_unstemmed Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
title_short Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
title_sort developmental competence and pluripotency gene expression of cattle cloned embryos derived from donor cells treated with 5 aza 2 deoxycytidine
topic epigenesis
nuclear reprogramming
nuclear transfer
url http://www.ijfs.ir/article_45069_0fbede76ae076f8b851bc96d3cbede2b.pdf
work_keys_str_mv AT farnooshjafarpour developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT sayedmortezahosseini developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT mahdihajian developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT mohsenforouzanfar developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT parvanehabedi developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT lalehhosseini developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT somayeostadhosseini developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT soghragholami developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine
AT mohammadhosseinnasresfahani developmentalcompetenceandpluripotencygeneexpressionofcattleclonedembryosderivedfromdonorcellstreatedwith5aza2deoxycytidine